Mücke VT - Search Results

1

Utility of the new cobas HCV test for viral load monitoring during direct-acting antiviral therapy.

Mücke MM, Maasoumy B, Dietz J, Mücke VT, Simon CO, Canchola JA, Cornberg M, Marins EG, Manns MP, Zeuzem S, Wedemeyer H, Sarrazin C, Vermehren J. Mücke MM, et al. Among authors: mucke vt. PLoS One. 2019 Nov 18;14(11):e0224751. doi: 10.1371/journal.pone.0224751. eCollection 2019. PLoS One. 2019. PMID: 31738773 Free PMC article.

2

Diagnosis and treatment of anemia in patients with inflammatory bowel disease.

Mücke V, Mücke MM, Raine T, Bettenworth D. Mücke V, et al. Ann Gastroenterol. 2017;30(1):15-22. doi: 10.20524/aog.2016.0083. Epub 2016 Sep 6. Ann Gastroenterol. 2017. PMID: 28042234 Free PMC article. Review.

3

Special populations: treating hepatitis C in patients with decompensated cirrhosis and/or advanced renal impairment.

Mücke MM, Mücke VT, Lange CM, Zeuzem S. Mücke MM, et al. Among authors: mucke vt. Liver Int. 2017 Jan;37 Suppl 1:19-25. doi: 10.1111/liv.13279. Liver Int. 2017. PMID: 28052635 Review.

4

No evidence of hepatitis B virus reactivation in patients with resolved infection treated with direct-acting antivirals for hepatitis C in a large real-world cohort.

Mücke VT, Mücke MM, Peiffer KH, Weiler N, Welzel TM, Sarrazin C, Zeuzem S, Berger A, Vermehren J. Mücke VT, et al. Among authors: mucke mm. Aliment Pharmacol Ther. 2017 Aug;46(4):432-439. doi: 10.1111/apt.14177. Epub 2017 Jun 19. Aliment Pharmacol Ther. 2017. PMID: 28627791

5

The role of Enterococcus spp. and multidrug-resistant bacteria causing pyogenic liver abscesses.

Mücke MM, Kessel J, Mücke VT, Schwarzkopf K, Hogardt M, Stephan C, Zeuzem S, Kempf VAJ, Lange CM. Mücke MM, et al. Among authors: mucke vt. BMC Infect Dis. 2017 Jun 26;17(1):450. doi: 10.1186/s12879-017-2543-1. BMC Infect Dis. 2017. PMID: 28651522 Free PMC article.

6

Bacterial infection-triggered acute-on-chronic liver failure is associated with increased mortality.

Mücke MM, Rumyantseva T, Mücke VT, Schwarzkopf K, Joshi S, Kempf VAJ, Welsch C, Zeuzem S, Lange CM. Mücke MM, et al. Among authors: mucke vt. Liver Int. 2018 Apr;38(4):645-653. doi: 10.1111/liv.13568. Epub 2017 Sep 15. Liver Int. 2018. PMID: 28853199

7

Letter: the potential risk of HBV reactivation in patients with resolved HBV infection during direct-acting antiviral therapy - authors' reply.

Mücke MM, Mücke VT, Vermehren J. Mücke MM, et al. Among authors: mucke vt. Aliment Pharmacol Ther. 2017 Oct;46(7):703-704. doi: 10.1111/apt.14259. Aliment Pharmacol Ther. 2017. PMID: 28880448 No abstract available.

8

Letter: low rates of HBV serology testing in patients with chronic hepatitis C receiving direct acting antivirals - Authors' reply.

Mücke MM, Mücke VT, Vermehren J. Mücke MM, et al. Among authors: mucke vt. Aliment Pharmacol Ther. 2017 Nov;46(9):909-910. doi: 10.1111/apt.14286. Aliment Pharmacol Ther. 2017. PMID: 29023880 No abstract available.

9

Hepatitis B virus reactivation during direct-acting antiviral therapy for hepatitis C: a systematic review and meta-analysis.

Mücke MM, Backus LI, Mücke VT, Coppola N, Preda CM, Yeh ML, Tang LSY, Belperio PS, Wilson EM, Yu ML, Zeuzem S, Herrmann E, Vermehren J. Mücke MM, et al. Among authors: mucke vt. Lancet Gastroenterol Hepatol. 2018 Mar;3(3):172-180. doi: 10.1016/S2468-1253(18)30002-5. Epub 2018 Jan 19. Lancet Gastroenterol Hepatol. 2018. PMID: 29371017 Review.

10

Managing hepatitis C in patients with the complications of cirrhosis.

Mücke MM, Mücke VT, Lange CM, Zeuzem S. Mücke MM, et al. Among authors: mucke vt. Liver Int. 2018 Feb;38 Suppl 1:14-20. doi: 10.1111/liv.13636. Liver Int. 2018. PMID: 29427491 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

37 results

Search Page

Filters